Magnetic nanoparticle aggregates can induce death of cancer cells

NewsGuard 100/100 Score

An international team in which a UPM researcher is involved has shown that it is possible to mechanically destroy cancer cells by rotating magnetic nanoparticles attached to them in elongated aggregates.

The project work led by Professor Yu Cheng from Tongji University (Shanghai, China) with the participation of Universidad Politécnica de Madrid (UPM) and other institutions from various countries has in vitro shown that it is possible to induce with very high effectiveness the death of cancer cells thanks to the force produced by the motion of magnetic nanoparticles aggregates. This new study, published in the Theranostics journal, combine the advantages of firstly the nanometric size of the particles to reach cancer cells, and secondly, the bigger size of aggregates to produce greater force required to induce the cell death.

Because of their singular properties, researchers have been developing a great amount of therapeutic applications using magnetic nanoparticles, especially for drug delivery systems and hyperthermia treatments for tumors. For this last example, the particles increase their temperature when are subjected to a magnetic field that vary to high frequency reaching values that can produce the death of cancer cells.

There are other studies that have developed applications to lower the risk of infections on implants and prostheses and promote the growth of tissues. In this context, the team of research, in which Professor Gustavo Plaza from the Centre for Biomedical Technology of UPM is involved, has proposed another research line less explored: the application of forces at nanometric scale with therapeutic purposes. The goal of this study was the production of forces high enough to lead the mechanical destruction of cancer cells.

The technique of functionalization allows researchers to modify the surface of nanoparticles by coating them with specific molecules in order to join certain types of cells. In the case of cancer treatment, the nanoparticles are covered with molecules that specifically join proteins that are expressed predominantly in cancer cells and not in healthy cells.

This research has used this method to treat cancer cells in vitro. It was proved that cells internalize the functionalized nanoparticles, mainly into lysosomes, which are small cell organelles. The application of an external relatively low magnetic field results in the formation of elongated nanoparticle aggregates.

Finally, under a low frequency rotating magnetic field we achieve the movement of nanoparticle aggregates that produce forces high enough to break the membrane of the lysosomes and the cell membrane, inducing the death of cancer cells with a very high effectiveness.

Previous works had used individual nanoparticles or particles of micrometric size (thousand times bigger than nanoparticles) to mechanically damage cancer cells. According to the researcher Gustavo Plaza, this new study combines the good properties of nanometric scale to reach the cancer cells and the greater size of aggregates to produce higher forces.

The UPM contribution to this work has been related to the estimation of magnetic fields and the forces exerted on the nanoparticle aggregates as well as the design of the experiments.

Source: http://www.upm.es/internacional/UPM/UPM_Channel/Research_News/153488ce6a0ac510VgnVCM10000009c7648aRCRD

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels